Correlation Between Eliem Therapeutics and Terns Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eliem Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Terns Pharmaceuticals.

Diversification Opportunities for Eliem Therapeutics and Terns Pharmaceuticals

0.87

Correlation Coefficient

Eliem Therapeutics  Terns Pharmaceuticals

Very poor diversification

The 3 months correlation between Eliem and Terns is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Terns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Terns Pharmaceuticals

Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Terns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.05 times less risky than Terns Pharmaceuticals. The stock trades about -0.24 of its potential returns per unit of risk. The Terns Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  723.00  in Terns Pharmaceuticals on September 2, 2024 and sell it today you would lose (99.00) from holding Terns Pharmaceuticals or give up 13.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	96.88%
Values	Daily Returns

Eliem Therapeutics  vs.  Terns Pharmaceuticals

Eliem Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Terns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Eliem Therapeutics and Terns Pharmaceuticals

The main advantage of trading using opposite Eliem Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.

The idea behind Eliem Therapeutics and Terns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.